Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,448 total, page 11 of 29
Dinner Time 2: Effect of Delayed Eating or Sleeping on Metabolism
NCT04671797
It's WeWomen Plus Intervention for Health, Safety and Empowerment
NCT04098276
Computer Delivered and Community Health Worker Supported Smoking Cessation Intervention
NCT04566159
Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry Eye
NCT04493658
AMP Step Wedge Trial
NCT05021679
Mindfulness Based Stress Reduction and Post-Stroke Cognition
NCT04302493
Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data
NCT04818151
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
NCT04170062
Preclinical Studies of Omalizumab in Chronic Rhinosinusitis With Nasal Polyposis
NCT04583501
Examining the Effectiveness of the myPlan App to Prevent Dating Violence With Adolescents
NCT04564261
Post-Operative Pain Control Following Shoulder Surgery
NCT04622839
Sensory Restoration After DIEP Flap Neurotization
NCT04533373
Mobile Acoustic Startle Reflex-monitoring System (MARS)
NCT04113850
Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use Disorder
NCT04287062
A Study of mDOT for Immunosuppressant Adherence in Solid Organ Transplant Recipients
NCT04587024
Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors
NCT04575896
PITA-HF: Feasibility, Safety, and Tolerability
NCT04159454
Single-sided Deafness and Cochlear Implantation
NCT05052944
An Innovative Intervention for OUD Treatment
NCT04325659
Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug
NCT04299490
Interactions Between Cannabinoids and Cytochrome P450-Metabolized Drugs
NCT04201197
Behavioral Pharmacology of THC and Alpha-pinene
NCT04130633
Oral Cannabidiol for Opioid Withdrawal
NCT04238754
Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis
NCT04583488
EUS-GE vs ES for Palliation of Gastric Outlet Obstruction
NCT03259763
Improving Self-Efficacy Through a Telenovela: Feasibility Study
NCT04533594
SHARE: Sharing Healthcare Wishes in Primary Care
NCT04593472
Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
NCT04362501
Comprehensive Imaging Exam of Convalesced COVID-19 Patients
NCT05920616
Music Listening as a Postanesthesia Care Unit (PACU) Nursing Intervention
NCT04596917
Clinical Utility of Handheld Hydrogen Breathalyzer in Identification of Food Sensitivities (AIRE Study)
NCT04309396
Transcutaneous Electroacupuncture for Gastrointestinal Motility Disorders
NCT04349891
Telerehabilitation Following Ankle Fractures
NCT04235907
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy - Part 2
NCT03638843
Circuitry Assessment and Reinforcement Training Effects on Recovery
NCT04290988
Extinction Learning in Adults With Tourette Syndrome
NCT04498364
Effects of Dietary Conditions on Drug Response
NCT04315961
Using Immersive Virtual Reality to Treat Pediatric Anxiety
NCT04504773
Behavioral Pharmacology of Cannabis and Nicotine
NCT04124432
Remote Guided Caffeine Reduction
NCT04560595
Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device
NCT03637374
Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" Study
NCT04517123
Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration
NCT03912220
Caregiver Support in the Context of Multiple Chronic Conditions
NCT04090749
Expansion of the Weigh Smart Pediatric Group Family Oriented Weight Management Program Through the Use of Telehealth
NCT04521595
A Fighting Chance: Pilot Study of a Group Mentoring Intervention for Assault Injured Youth
NCT04120441
HPV Vaccination Study in Postpartum Women
NCT04274153
Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis
NCT04261790
Human Behaviors Related to the Expectation of Pain
NCT03739645
Crizanlizumab for Treating COVID-19 Vasculopathy
NCT04435184
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.